Bionano Genomics, Inc. Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q2 2020 to Q4 2024

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Bionano Genomics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q2 2020 to Q4 2024.
  • Bionano Genomics, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending December 31, 2024 was 1.27M shares, a 123% increase year-over-year.
  • Bionano Genomics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 1.27M shares, a 123% increase from 2023.
  • Bionano Genomics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 569K shares, a 98% decline from 2022.
  • Bionano Genomics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 28.9M shares, a 89.6% decline from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 1.27M +702K +123% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-31
Q3 2024 85.9M +50.9M +145% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 67.6M +36.1M +115% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 52.7M +22.5M +74.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 569K -28.4M -98% Oct 1, 2023 Dec 31, 2023 10-K 2025-03-31
Q3 2023 35M +6.03M +20.8% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 31.5M +2.94M +10.3% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 30.2M -254M -89.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 28.9M -248M -89.6% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-05
Q3 2022 29M -251M -89.7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 28.6M -250M -89.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 285M +20.7M +7.83% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 277M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-09
Q3 2021 280M +147M +111% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 279M +188M +207% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 264M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q3 2020 133M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 90.9M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.